Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market.
Lilly's rival Danish firm Novo Nordisk is also working to bring its obesity drug Wegovy (Semaglutide) to India soon, and ...
Zepbound outperformed Wegovy for weight loss in a new clinical trial funded by Eli Lilly & Co., Zepbound's maker.
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
The proposed buyout of contract drug manufacturer Catalent won’t raise competition concerns, the European Commission said.
Weight-loss drugs like Ozempic seem like a miracle. But they've also created a gold rush for online scammers and hucksters.
Netflix France’s boxing drama has been making waves on Netflix around the globe since its debut on November 8th, 2024, with the streamer confirming that the show created by Franck Gastambide and ...